Uptake and acceptability of a mainstreaming model of hereditary cancer multigene panel testing among patients with ovarian, pancreatic, and prostate cancerJada G. Hamilton, Susan M. Domchek, Rebecca Mueller et al.|Genetics in Medicine|2021Cited by 73
Prevalence Of BRCA1/2 In An Ovarian Cancer Cohort: Outcomes From A Nationwide Testing ProgramCiara S. McNevin, Karen A. Cadoo, Rachel Dillion et al.|International Journal of Gynecological Cancer|2025Cited by 0